'en:tazasubrate'
(id=7188422 ; fe=en:tazasubrate ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=898 creation date=2017-06-26 touchdate=2025-08-14 00:24:37.000) ≈ 21 relations sortantes
- en:tazasubrate --
r_associated #0: 20 / 1 ->
acide pidolique
n1=en:tazasubrate | n2=acide pidolique | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
acide pyroglutamique
n1=en:tazasubrate | n2=acide pyroglutamique | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
anacetrapib
n1=en:tazasubrate | n2=anacetrapib | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:anacetrapib
n1=en:tazasubrate | n2=en:anacetrapib | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:azacosterol hydrochloride
n1=en:tazasubrate | n2=en:azacosterol hydrochloride | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:azalanstat
n1=en:tazasubrate | n2=en:azalanstat | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:benzmalecene
n1=en:tazasubrate | n2=en:benzmalecene | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:eflucimibe
n1=en:tazasubrate | n2=en:eflucimibe | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:ethyl icosapentate
n1=en:tazasubrate | n2=en:ethyl icosapentate | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:ezetimibe
n1=en:tazasubrate | n2=en:ezetimibe | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:ezetimibe/simvastatin
n1=en:tazasubrate | n2=en:ezetimibe/simvastatin | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:hmg-coa reductase inhibitor
n1=en:tazasubrate | n2=en:hmg-coa reductase inhibitor | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:lomitapide
n1=en:tazasubrate | n2=en:lomitapide | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:omega-3 acid ethyl esters (usp)
n1=en:tazasubrate | n2=en:omega-3 acid ethyl esters (usp) | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:pidolic acid
n1=en:tazasubrate | n2=en:pidolic acid | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:pyroglutamic acid
n1=en:tazasubrate | n2=en:pyroglutamic acid | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:sorbinicate
n1=en:tazasubrate | n2=en:sorbinicate | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:sunagrel
n1=en:tazasubrate | n2=en:sunagrel | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
en:vytorin
n1=en:tazasubrate | n2=en:vytorin | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
ézétimibe
n1=en:tazasubrate | n2=ézétimibe | rel=r_associated | relid=0 | w=20
- en:tazasubrate --
r_associated #0: 20 / 1 ->
lomitapide
n1=en:tazasubrate | n2=lomitapide | rel=r_associated | relid=0 | w=20
| ≈ 24 relations entrantes
- acide pidolique ---
r_associated #0: 73 -->
en:tazasubrate
n1=acide pidolique | n2=en:tazasubrate | rel=r_associated | relid=0 | w=73
- acide pyroglutamique ---
r_associated #0: 66 -->
en:tazasubrate
n1=acide pyroglutamique | n2=en:tazasubrate | rel=r_associated | relid=0 | w=66
- en:pidolic acid ---
r_associated #0: 66 -->
en:tazasubrate
n1=en:pidolic acid | n2=en:tazasubrate | rel=r_associated | relid=0 | w=66
- en:anacetrapib ---
r_associated #0: 59 -->
en:tazasubrate
n1=en:anacetrapib | n2=en:tazasubrate | rel=r_associated | relid=0 | w=59
- anacetrapib ---
r_associated #0: 55 -->
en:tazasubrate
n1=anacetrapib | n2=en:tazasubrate | rel=r_associated | relid=0 | w=55
- ézétimibe ---
r_associated #0: 50 -->
en:tazasubrate
n1=ézétimibe | n2=en:tazasubrate | rel=r_associated | relid=0 | w=50
- en:ezetimibe ---
r_associated #0: 47 -->
en:tazasubrate
n1=en:ezetimibe | n2=en:tazasubrate | rel=r_associated | relid=0 | w=47
- en:ethyl icosapentate ---
r_associated #0: 35 -->
en:tazasubrate
n1=en:ethyl icosapentate | n2=en:tazasubrate | rel=r_associated | relid=0 | w=35
- en:ezetimibe/simvastatin ---
r_associated #0: 34 -->
en:tazasubrate
n1=en:ezetimibe/simvastatin | n2=en:tazasubrate | rel=r_associated | relid=0 | w=34
- en:omega-3 acid ethyl esters (usp) ---
r_associated #0: 34 -->
en:tazasubrate
n1=en:omega-3 acid ethyl esters (usp) | n2=en:tazasubrate | rel=r_associated | relid=0 | w=34
- en:sorbinicate ---
r_associated #0: 34 -->
en:tazasubrate
n1=en:sorbinicate | n2=en:tazasubrate | rel=r_associated | relid=0 | w=34
- en:vytorin ---
r_associated #0: 34 -->
en:tazasubrate
n1=en:vytorin | n2=en:tazasubrate | rel=r_associated | relid=0 | w=34
- en:lomitapide ---
r_associated #0: 32 -->
en:tazasubrate
n1=en:lomitapide | n2=en:tazasubrate | rel=r_associated | relid=0 | w=32
- lomitapide ---
r_associated #0: 32 -->
en:tazasubrate
n1=lomitapide | n2=en:tazasubrate | rel=r_associated | relid=0 | w=32
- en:benzmalecene ---
r_associated #0: 31 -->
en:tazasubrate
n1=en:benzmalecene | n2=en:tazasubrate | rel=r_associated | relid=0 | w=31
- en:eflucimibe ---
r_associated #0: 31 -->
en:tazasubrate
n1=en:eflucimibe | n2=en:tazasubrate | rel=r_associated | relid=0 | w=31
- en:sunagrel ---
r_associated #0: 31 -->
en:tazasubrate
n1=en:sunagrel | n2=en:tazasubrate | rel=r_associated | relid=0 | w=31
- en:azacosterol hydrochloride ---
r_associated #0: 29 -->
en:tazasubrate
n1=en:azacosterol hydrochloride | n2=en:tazasubrate | rel=r_associated | relid=0 | w=29
- en:hmg-coa reductase inhibitor ---
r_associated #0: 28 -->
en:tazasubrate
n1=en:hmg-coa reductase inhibitor | n2=en:tazasubrate | rel=r_associated | relid=0 | w=28
- en:azalanstat ---
r_associated #0: 26 -->
en:tazasubrate
n1=en:azalanstat | n2=en:tazasubrate | rel=r_associated | relid=0 | w=26
- en:pyroglutamic acid ---
r_associated #0: 26 -->
en:tazasubrate
n1=en:pyroglutamic acid | n2=en:tazasubrate | rel=r_associated | relid=0 | w=26
- en:probucol ---
r_associated #0: 25 -->
en:tazasubrate
n1=en:probucol | n2=en:tazasubrate | rel=r_associated | relid=0 | w=25
- Ézétimibe ---
r_associated #0: 10 -->
en:tazasubrate
n1=Ézétimibe | n2=en:tazasubrate | rel=r_associated | relid=0 | w=10
- évitement (conduite d') ---
r_associated #0: 10 -->
en:tazasubrate
n1=évitement (conduite d') | n2=en:tazasubrate | rel=r_associated | relid=0 | w=10
|